News
13h
Zacks Investment Research on MSNCVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...
Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...
CVS Health (CVS) closed the most recent ... and the technology-dominated Nasdaq saw a decrease of 3.07%. The the stock of drugstore chain and pharmacy benefits manager has risen by 2% in the ...
Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...
In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp ...
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...
Shares of CVS Health jumped after the company reported a strong first quarter and agreed to open up access to Novo Nordisk's weight-loss medication at more affordable prices. The stock was up 8.7% at ...
Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results